In vivo human skin permeability enhancement by oleic acid: A laser Doppler velocimetry study

Journal of Controlled Release

Volumn 58, Issue 1, 1999, Pages 97-104

  Tanojo, Hanafi ^a   Boelsma, Esther ^b   Junginger, Hans E ^c   Ponec, Maria ^b   Boddé, Harry E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Human, in vivo study; Laser Doppler velocimetry; Oleic acid; Skin permeability; Topical application

Indexed keywords

NICOTINIC ACID HEXYL ESTER; OLEIC ACID; PENETRATION ENHANCING AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN IRRITATION; SKIN PENETRATION; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION; VASODILATATION; VOLUNTEER;

ADMINISTRATION, TOPICAL; ADULT; EMULSIONS; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; NICOTINIC ACIDS; OLEIC ACID; PERMEABILITY; PHARMACEUTIC AIDS; REGIONAL BLOOD FLOW; SKIN; SKIN ABSORPTION; SOLUTIONS; VASODILATOR AGENTS;

EID: 0032799361     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00144-8     Document Type: Article

References (39)

1. R.J. Scheuplein, I.H. Blank, Permeability of the skin, Physiol. Rev. 51 (1971) 702-747.
2. J.E. Shaw, J. Urquhart, Transdermal drug administration - a nuisance becomes an opportunity, Br. Med. J. 283 (1981) 875-876.
3. B.J. Aungst, Fatty acids as skin permeation enhancers, in: E.W. Smith, H.I. Maibach (Eds.), Percutaneous Penetration Enhancers, CRC Press, Boca Raton, FL, 1995, pp. 277-287.
4. P.G. Green, R.H. Guy, J. Hadgraft, In vitro and in vivo enhancement of skin permeation with oleic and lauric acids, Int. J. Pharm. 48 (1988) 103-111.
5. H. Tanojo, J.A. Bouwstra, H.E. Junginger, H.E. Boddé, Effects of oleic acid on human transepidermal water loss using ethanol or propylene glycol as vehicles, in: K.R. Brain, V.J. James, K.A. Walters (Eds.), Prediction of Percutaneous Penetration, Vol. 3b, STS, Cardiff, 1993, pp. 319-324.
6. R. Kohli, W.I. Archer, J.M.C. Roberts, A.J. Cochran, A. Li Wan Po, Impedance measurements for the non-invasive monitoring of skin hydration: a reassessment, Int. J. Pharm. 26 (1985) 275-287.
7. V.H.W. Mak, R.O. Potts, R.H. Guy, Oleic acid concentration and effect in stratum corneum determined in vivo by infrared spectroscopy, J. Invest. Dermatol. 90 (1988) 584.
8. A.W. McKenzie, R.M.M. Atkinson, Topical activities of betamethasone esters in man, Arch. Dermatol. 89 (1964) 741-746.
9. R.H. Guy, R.C. Wester, E. Tur, H.I. Maibach, Noninvasive assessments of the percutaneous absorption of methyl nicotinate in humans, J. Pharm. Sci. 72 (1983) 1077-1079.
10. M.D. Stern, In vivo evaluation of microcirculation by coherent light scattering, Nature 254 (1975) 56-58.
11. G.E. Nilsson, U. Otto, J.E. Wahlberg, Assessment of skin irritancy in man by laser-Doppler flowmetry, Contact Dermatitis 8 (1982) 401-406.
12. T. Agner, Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls, Acta Derm. Venereol. (Stockh.), Suppl. 178 (1992) 3-26.
13. R. Blanken, P.G.M. Van der Valk, J.P. Nater, Laser-Doppler flowmetry in the investigation of irritant compounds on human skin, Dermatosen 34 (1986) 5-9.
14. E. Berardesca, H.I. Maibach, Bioengineering and the patch test, Contact Dermatitis 18 (1988) 3-9.
15. G.P. Fulton, E.M. Farber, A.P. Moreci, The mechanism of action of rubefacients, J. Invest. Dermatol. 33 (1959) 317-325.
16. V Henschel, F. Jaminet, Absorption percutanée d'esters de l'acide nicotinique Influence des excipients, J. Pharm. Belg. 27 (1972) 743-754.
17. K.S. Ryatt, J.M. Stevenson, H.I. Maibach, R.H. Guy, Pharmacodynamic measurement of percutaneous penetration enhancement in vivo, J. Pharm. Sci. 75 (1986) 374-377.
18. R. Kohli, W.I. Archer, A. Li Wan Po, Laser velocimetry for the non-invasive assessment of the percutaneous absorption of nicotinates, Int. J. Pharm. 36 (1987) 91-98.
19. M. Meloni, M.C. Poelman, M. Lavazza, LDV assessment of methyl nicotinate biological response in aqueous solution against that of a w/o microemulsion system, Int. J. Cosm. Sci. 16 (1994) 257-264.
20. E. Oestmann, A.P.M. Lavrijsen, J. Hermans, M. Ponec, Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and inter-individual variability, Br. J. Dermatol. 128 (1993) 130-136.
21. B. Staberg, P. Klem, J. Serup, Patch test responses evaluated by cutaneous blood flow measurements, Arch. Dermatol. 120 (1984) 741-743.
22. T. Loftsson, N. Gildersleeve, N. Bodor, The effect of vehicle additives on the transdermal delivery of nitroglycerin, Pharm. Res. 4 (1987) 436-437.
23. M.A. Stillman, H.I. Maibach, A.R. Shalita, Relative irritancy of free fatty acids of different chain length, Contact Dermatitis 1 (1975) 65-69.
24. P.J. Frosch, A.M. Kligman, The chamber-scarification test for irritancy, Contact Dermatitis 2 (1976) 314-324.
25. H. Tanojo, H.E. Junginger, H.E. Boddé, In vivo human skin permeability enhancement by oleic acid: Transepidermal water loss and Fourier-transform infrared spectroscopy studies, J. Controlled Rel. 47 (1997) 31-39.
26. E. Boelsma, H. Tanojo, H.E. Boddé, M. Ponec, Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivo, Toxic, in Vitro 10 (1996) 729-742.
27. H. Tanojo, E. Boelsma, H.E. Junginger, M. Ponec, H.E. Boddé, In vitro human skin permeability enhancement by oleic acid and propylene glycol: Permeation of p-amino-benzoic acid and oleic acid across stratum corneum, submitted for publication.
28. J.O. Funk, H.I. Maibach, Propylene glycol dermatitis: reevaluation of an old problem, Contact Dermatitis 31 (1994) 236-241.
29. R.H. Guy, E. Tur, B. Bugatto, C. Gaebel, L.B. Sheiner, H.I. Maibach, Pharmacodynamic measurements of methyl nicotinate percutaneous absorption, Pharm. Res. 1 (1984) 76-81.
30. H. Osamura, Penetration of topical corticosteroids through human epidermis, J. Dermatol. 9 (1982) 45-58.
31. R.H. Guy, E.M. Carlström, D.A. Bucks, R.S. Hinz, H.I. Maibach, Percutaneous penetration of nicotinates: in vivo and in vitro measurements, J. Pharm. Sci. 75 (1986) 968-972.
32. P.M. Elias, Lipids and the epidermal permeability barrier, Arch. Dermatol. Res. 120 (1981) 95-117.
33. W.J. Albery, J. Hadgraft, Percutaneous absorption: in vivo experiments, J. Pharm. Pharmacol. 31 (1979) 140-147.
34. J.L. Zatz, U.G. Dalvi, Evaluation of solvent-skin interaction in percutaneous absorption, J. Soc. Cosmet. Chem. 34 (1983) 327-334.
35. M.L. Williams, P.M. Elias, The extracellular matrix of stratum corneum: role of lipids in normal and pathological function, Crit. Rev. Ther. Drug Carrier Syst. 3 (1987) 95-122.
36. O. Simonetti, A.J. Hoogstraate, W Bialik, J.A. Kempenaar, A.H.G.J. Schrijvers, H.E. Boddé, M. Ponec, Visualization of diffusion pathways across the stratum corneum of native and in-vitro-reconstructed epidermis by confocal laser scanning microscopy, Arch. Dermatol. Res. 287 (1995) 465-473.
37. R.O. Potts, Physical characterization of the stratum corneum: the relationship of mechanical and barrier properties to lipid and protein structure, in: J. Hadgraft, R.H. Guy (Eds.), Transdermal Drug Delivery: Developmental Issues and Research Initiatives, Marcel Dekker, New York, 1989, pp. 23-57.
38. A.J. Hoogstraate, J. Verhoef, J. Brusee, A.P. IJzerman, F. Spies, H.E. Boddé, Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkylazacycloheptanones, Int. J. Pharm. 76 (1991) 37-47.
39. J.A. Bouwstra, M.A. Salomons-de Vries, B.A.I, van den Bergh, G.S. Gooris, Changes in lipid organisation of the skin barrier by N-alkyl-azocycloheptanones: a visualisation and X-ray diffraction study, Int. J. Pharm. 144 (1996) 81-89.